Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 48c
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Join SI Premium – FREE
Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.45), $0.48 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $225 million versus the consensus estimate of $152.34 million.
For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Lockheed Martin wins $83 million Army missile contract
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
